Journal ArticleJ Immunother Cancer · October 15, 2025
Immune checkpoint inhibitors (ICIs) are an important class of cancer treatment. Endocrine immune-related adverse events (E-irAEs) account for a significant proportion of irAEs in ICI-treated patients. Diagnosing E-irAEs accurately and timely can be challen ...
Full textLink to itemCite
Journal ArticleJCEM Case Rep · March 2025
Acquired generalized lipodystrophy (AGL) is rarely associated with immune checkpoint inhibitors (ICIs). A few cases report associations with inhibitors to programmed cell death protein 1 (PD-1 inhibitors); however, association with combined immunotherapies ...
Full textLink to itemCite
Journal ArticleEndocr Pract · June 2024
OBJECTIVE: To provide a clinical approach towards immune checkpoint inhibitor (ICI)-associated endocrinopathies, their link with cancer outcomes, factors which differentiate them from other immune related adverse events, and health systems innovation to im ...
Full textLink to itemCite
Journal ArticleJ Clin Med · December 29, 2019
Acute myocardial infarction (AMI) is one of the most common causes of death in both the developed and developing world. It has high associated morbidity despite prompt institution of recommended therapy. The focus over the last few decades in ST-segment el ...
Full textLink to itemCite
Journal ArticleInterdisciplinary Neurosurgery Advanced Techniques and Case Management · June 1, 2019
It is because of the distribution of the MCA that isolated aphasia is uncommon. This case reminds us of the risk of stroke in illicit drug use while highlighting another cause of stroke with isolated aphasia. We present a 50 year old male with no prior med ...
Full textCite